Charles D. Lopez
- Oncology top 2%
- Molecular Biology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Co-authors
- Vishwanath R. LingappaC. Spencer YostStanley B. PrusinerLouie NaumovskiZhiyi ZhuDexi ChenZhiyong YuR Myers
- Topics
- Pancreatic and Hepatic Oncology Research (43 papers)Cancer Genomics and Diagnostics (24 papers)Cancer-related Molecular Pathways (16 papers)
- Cited by
- OncologyCancer ResearchNeurology
- Partner nations
- United StatesGermanySpain
In The Last Decade
Charles D. Lopez
92 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 109
- Oncology 1.0k
- Molecular Biology 987
- Cancer Research 375
- Pulmonary and Respiratory Medicine 223
- Immunology 201
Countries citing papers authored by Charles D. Lopez
This map shows the geographic impact of Charles D. Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Lopez more than expected).
Fields of papers citing papers by Charles D. Lopez
This network shows the impact of papers produced by Charles D. Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Lopez. The network helps show where Charles D. Lopez may publish in the future.
Co-authorship network of co-authors of Charles D. Lopez
This figure shows the co-authorship network connecting the top 25 collaborators of Charles D. Lopez. A scholar is included among the top collaborators of Charles D. Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles D. Lopez. Charles D. Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 0 | |
| 11 | 78 | |
| 12 | 3 | |
| 13 | 1 | |
| 14 | 62 | |
| 15 | 1 | |
| 16 | 198 | |
| 17 | FG-3019, A Human Monoclonal Antibody to Connective Tissue Growth Factor, Combined with Chemotherapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | 8 |
| 18 | 10 | |
| 19 | 18 | |
| 20 | 36 |
About Charles D. Lopez
Charles D. Lopez is a scholar working on Oncology, Cancer Research and Hepatology, having authored 97 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (43 papers), Cancer Genomics and Diagnostics (24 papers) and Cancer-related Molecular Pathways (16 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (375 citations) and Neurology (122 citations). Charles D. Lopez has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Vishwanath R. Lingappa, C. Spencer Yost, Stanley B. Prusiner, Louie Naumovski, Zhiyi Zhu, Dexi Chen, Zhiyong Yu, R Myers, Brett C. Sheppard and Kerstin Maria Kampa-Schittenhelm. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.